SEGMENT AND RELATED INFORMATION (Tables)

12 Months Ended

Dec. 31, 2014

SEGMENT AND RELATED INFORMATION

Summary of financial information concerning the Company's operating segments

(in thousands)	Patient Care		Products &  Services		Corporate & Other			Consolidating Adjustments			Total
2014
Net revenue
Third Party	$	837,080	$	175,020	$	—		$	—		$	1,012,100
Intersegments	—		183,640		—			(183,640		)	—
Total net revenue	837,080		358,660		—			(183,640		)	1,012,100
Material costs
Third party suppliers	240,685		83,599		—			—			324,284
Intersegments	40,591		143,049		—			(183,640		)	—
Total material costs	281,276		226,648		—			(183,640		)	324,284
Personnel costs	305,651		47,935		—			—			353,586
Other expenses	152,176		27,721		88,124			—			268,021
Depreciation and amortization	18,769		12,022		8,138			—			38,929
Income from continuing operations	79,208		44,334		(96,262		)	—			27,280
Interest expense (income)	33,465		13,079		(18,267		)	—			28,277
Income (loss) from continuing operations before income taxes	45,743		31,255		(77,995		)	—			(997		)
Provision for income taxes	—		—		2,023			—			2,023
Net income (loss) from continuing operations	$	45,743	$	31,255	$	(80,018	)	$	—		$	(3,020	)
EBITDA	97,977		56,356		(88,124		)	—			66,209
Total assets	848,051		262,721		191,533			—			1,302,305
Capital expenditures	14,067		1,305		11,724			—			27,096

(in thousands)	Patient Care		Products &  Services		Corporate & Other			Consolidating Adjustments			Total
2013 (As Restated)
Net revenue
Third Party	$	803,180	$	172,589	$	—		$	—		$	975,769
Intersegments	—		222,899		—			(222,899		)	—
Total net revenue	803,180		395,488		—			(222,899		)	975,769
Material costs
Third party suppliers	226,646		75,357		—			—			302,003
Intersegments	37,914		184,985		—			(222,899		)	—
Total material costs	264,560		260,342		—			(222,899		)	302,003
Personnel costs	279,089		46,691		—			—			325,780
Other expenses	129,090		25,660		45,496			—			200,246
Depreciation and amortization	14,468		12,548		7,169			—			34,185
Income from continuing operations	115,973		50,247		(52,665		)	—			113,555
Interest expense (income)	33,198		14,470		(17,092		)	—			30,576
Extinguishment of debt	—		—		6,645			—			6,645
Income from continuing operations before income taxes	82,775		35,777		(42,218		)	—			76,334
Provision for income taxes	—		—		30,455			—			30,455
Net income from continuing operations	$	82,775	$	35,777	$	(72,673	)	$	—		$	45,879
EBITDA	130,441		62,795		(45,496		)	—			147,740
Total assets	805,248		259,955		149,785			—			1,214,988
Capital expenditures	10,821		535		14,551			—			25,907

(in thousands)	Patient Care		Products &  Services		Corporate & Other			Consolidating Adjustments			Total
2012 (As Restated)
Net revenue
Third Party	$	752,425	$	171,096	$	—		$	—		$	923,521
Intersegments	—		208,823		—			(208,823		)	—
Total net revenue	752,425		379,919		—			(208,823		)	923,521
Material costs
Third party suppliers	205,538		80,335		—			—			285,873
Intersegments	35,933		172,890		—			(208,823		)	—
Total material costs	241,471		253,225		—			(208,823		)	285,873
Personnel costs	252,568		46,436		—			—			299,004
Other expenses	120,934		28,292		47,744			—			196,970
Depreciation and amortization	13,030		12,688		6,871			—			32,589
Income from continuing operations	124,422		39,278		(54,615		)	—			109,085
Interest expense (income)	32,476		9,325		(7,181		)	—			34,620
Income from continuing operations before income taxes	91,946		29,953		(47,434		)	—			74,465
Provision for income taxes	—		—		26,206			—			26,206
Net income from continuing operations	$	91,946	$	29,953	$	(73,640	)	$	—		$	48,259
EBITDA	137,452		51,966		(47,744		)	—			141,674
Total assets	794,698		258,915		147,675			—			1,201,288
Capital expenditures	7,460		2,745		14,298			—			24,503